InvestorsHub Logo
Followers 839
Posts 120498
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 810

Friday, 03/20/2020 1:34:30 PM

Friday, March 20, 2020 1:34:30 PM

Post# of 1169
BMY/BMY-R—Delayed pivotal trials and FDA reviews could let BMY off the hook for the $9/sh CVR payable to CELG shareholders.

Related comments fro Vantage:
https://www.evaluate.com/vantage/articles/analysis/clinical-trial-delays-become-reality-covid-19-risk-spreads

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News